Novavax, Inc. (BMV:NVAX)

Novavax Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,509	26,836	9,640	17,241	221,759	81,162
Market Cap Growth	178.39%	178.39%	-44.09%	-92.23%	173.23%	4510.87%
Enterprise Value	13,966	13,348	3,018	5,861	191,455	84,178
Last Close Price	170.04	167.00	81.41	200.00	2936.67	2220.00
PS Ratio	1.89	1.89	0.58	0.45	9.44	8.58
PB Ratio	-2.06	-2.06	-0.80	-1.39	-30.76	6.50
P/TBV Ratio	-	-	-	-	-	8.39
P/FCF Ratio	-	-	-	-	40.30	-
P/OCF Ratio	-	-	-	-	33.50	-
EV/Sales Ratio	1.00	0.94	0.18	0.15	8.15	8.89
EV/FCF Ratio	-6.68	-	-	-	34.79	-
Debt / Equity Ratio	-0.42	-0.42	-0.39	-0.97	-1.49	0.77
Debt / FCF Ratio	-	-	-	-	1.95	-
Asset Turnover	0.41	0.41	0.49	0.82	0.55	0.54
Inventory Turnover	22.58	22.58	26.47	90.94	-	-
Quick Ratio	0.89	0.89	0.53	0.58	0.82	1.68
Current Ratio	0.98	0.98	0.70	0.69	0.90	2.15
Return on Equity (ROE)	-	-	-	-	-1265.72%	-189.60%
Return on Assets (ROA)	-8.63%	-8.63%	-17.02%	-16.67%	-50.69%	-29.48%
Return on Capital (ROIC)	-	-	-	-519.71%	-164.51%	-41.57%
Earnings Yield	-14.20%	-14.56%	-95.59%	-74.44%	-16.12%	-10.25%
FCF Yield	-7.60%	-7.79%	-134.65%	-57.13%	2.48%	-2.38%
Buyback Yield / Dilution	-51.03%	-51.03%	-28.89%	-5.08%	-29.27%	-138.81%
Total Shareholder Return	-51.03%	-51.03%	-28.89%	-5.08%	-29.27%	-138.81%

Source: S&P Capital IQ. Standard template. Financial Sources.